Bharat Biotech dispatches three lakh doses of intranasal COVID vaccine to hospitals Ruchika Sharma6 Feb 2023 4:30 AM GMTiNCOVACC is the world's first intranasal COVID-19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster dose for...
Dr Mansukh Mandaviya unveils Bharat Biotech intransal COVID vaccine iNCOVACC Ruchika Sharma27 Jan 2023 6:42 AM GMTiNCOVACC is a cost-effective covid vaccine which does not require syringes, needles, alcohol wipes, bandage, etc, saving costs related to procurement,...
Intranasal COVID vaccine: Bharat Biotech to launch iNCOVACC on January 26 MD Bureau23 Jan 2023 5:45 AM GMTINCOVACC is a nasal vaccine indicated for active immunization against SARS-CoV-2 virus infection.
Bharat Biotech INCOVACC to cost Rs 800 for Private hospitals, Rs 325 for Govt Isra Zaman28 Dec 2022 11:22 AM GMTBharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs...
Health Bulletin 28/December/2022 Isra Zaman28 Dec 2022 11:06 AM GMTHere are the top health stories for the day:Bharat Biotech's iNCOVACC: India's 1st intranasal vaccine to cost Rs 800 in private markets, Rs 325 for...
COVID intranasal vaccine: Bharat Biotech iNCOVACC priced at Rs 800 for private hospitals, Rs 325 for Govt Ruchika Sharma27 Dec 2022 9:00 AM GMTiNCOVACC is the world's first intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose.
Health Bulletin 24/ December/ 2022 Roshni Dhar24 Dec 2022 11:02 AM GMTHere are the top health stories for the day:Fully prepared to deal with any eventuality, say Delhi hospitals amid coronavirus scareAmid concerns over...
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 10:01 AM GMTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
Include intranasal COVID vaccine iNCOVACC in CoWIN portal: Bharat Biotech urges Centre Ruchika Sharma12 Dec 2022 7:00 AM GMTCurrently, Bharat Biotech's Covaxin, Serum Institute's Covishield and Covovax, Russian Sputink V, and Biological E Ltd's Corbevax are listed in the...
DCGI gives nod to Bharat Biotech Intranasal 'Five Arms' COVID booster dose for restricted use Ruchika Sharma26 Nov 2022 6:00 AM GMTThe nasal vaccine can be taken after six months of the second dose. As this is non-invasive and needle-free, it becomes easy to administer.
DCGI panel to hold discussion on intranasal "Five Arms" booster dose iNCOVACC on Nov 15: Sources Ruchika Sharma14 Nov 2022 8:00 AM GMTIt has now announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency Situation for ages 18 and above.
Intranasal COVID vaccine: Bharat Biotech seeks DCGI nod for phase 3 study of iNCOVACC in 5-18 age group Ruchika Sharma12 Sep 2022 5:58 AM GMTiNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
